# Transcode Therapeutics, Inc.: filings

RNAZ · Nasdaq · CIK 1829635 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rnaz.md) · [Financials](/companies/rnaz/financials.md) · [Filings](/companies/rnaz/filings.md) · [Insiders](/companies/rnaz/insiders.md)

## Reports and events: 150 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 82, 4 31, CORRESP 28, DEFA14A 19, 10-Q 16, S-1/A 12, 3 11, DEF 14A 9, EFFECT 9, UPLOAD 9, S-1 8, 424B5 7, PRE 14A 7, SC 13G/A 7, SC 13G 6, SCHEDULE 13G 6, 10-K 5, 8-K/A 5, SCHEDULE 13D/A 5, 424B4 4, ARS 3, S-3 3, 10-K/A 2, 424B3 2, DRS 2, NT 10-K 2, RW 2, S-8 2, SC 13D 2, SC 13D/A 2, SCHEDULE 13D 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 4/A 1, 8-A12B 1, CERT 1, D 1, DEFR14A 1, DRS/A 1, DRSLTR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 20:05 ET | [8-K](/filings/0001104659-26-112826.md) | 1.01 Entry into a material agreement; 2.04 Item not in the standard list | 0001104659-26-112826 |
| 2026-09-28 | 12:16 ET | [8-K](/filings/0001104659-26-111170.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-111170 |
| 2026-09-11 | 21:00 ET | [8-K](/filings/0001104659-26-107115.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-107115 |
| 2026-08-14 | 21:05 ET | [10-Q](/filings/0001829635-26-000003.md) | Quarterly report, period 2026-06-30 | 0001829635-26-000003 |
| 2026-08-03 | 20:38 ET | [SCHEDULE 13D/A](/filings/0001104659-26-089819.md) | Ownership report, active investor, amended | 0001104659-26-089819 |
| 2026-08-03 | 20:15 ET | [8-K](/filings/0001104659-26-089805.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-089805 |
| 2026-07-27 | 20:15 ET | [SCHEDULE 13D/A](/filings/0001104659-26-087098.md) | Ownership report, active investor, amended | 0001104659-26-087098 |
| 2026-07-23 | 20:15 ET | [SCHEDULE 13D/A](/filings/0001104659-26-086266.md) | Ownership report, active investor, amended | 0001104659-26-086266 |
| 2026-07-20 | 20:15 ET | [8-K](/filings/0001104659-26-085073.md) | 5.07 Shareholder vote results | 0001104659-26-085073 |
| 2026-07-17 | 20:15 ET | [SCHEDULE 13D/A](/filings/0001104659-26-084636.md) | Ownership report, active investor, amended | 0001104659-26-084636 |
| 2026-07-17 | 20:05 ET | [8-K](/filings/0001104659-26-084617.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-084617 |
| 2026-07-02 | 20:05 ET | [8-K](/filings/0001104659-26-080311.md) | 8.01 Other events | 0001104659-26-080311 |
| 2026-06-18 | 12:00 ET | [8-K](/filings/0001104659-26-075440.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-075440 |
| 2026-06-03 | 12:08 ET | [8-K](/filings/0001104659-26-069810.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-069810 |
| 2026-06-02 | 20:05 ET | [DEF 14A](/filings/0001104659-26-069458.md) | Proxy statement, period 2026-07-02 | 0001104659-26-069458 |
| 2026-06-01 | 12:59 ET | [8-K](/filings/0001104659-26-068647.md) | 5.08 Item not in the standard list | 0001104659-26-068647 |
| 2026-05-26 | 10:43 ET | [8-K/A](/filings/0001104659-26-065959.md) | 3.01 Delisting notice | 0001104659-26-065959 |
| 2026-05-22 | 20:15 ET | [8-K](/filings/0001104659-26-065728.md) | 3.01 Delisting notice | 0001104659-26-065728 |
| 2026-05-15 | 20:10 ET | [10-Q](/filings/0001104659-26-062535.md) | Quarterly report, period 2026-03-31 | 0001104659-26-062535 |
| 2026-05-01 | 00:58 ET | [S-1](/filings/0001104659-26-053289.md) | Registration statement | 0001104659-26-053289 |
| 2026-04-30 | 20:15 ET | [10-K/A](/filings/0001104659-26-052941.md) | Annual report, amended, period 2025-12-31 | 0001104659-26-052941 |
| 2026-04-15 | 20:17 ET | [10-K](/filings/0001104659-26-043810.md) | Annual report, period 2025-12-31 | 0001104659-26-043810 |
| 2026-04-07 | 12:35 ET | [8-K](/filings/0001104659-26-040171.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-040171 |
| 2026-03-03 | 21:05 ET | [8-K](/filings/0001104659-26-022830.md) | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-022830 |
| 2026-02-23 | 13:10 ET | [8-K](/filings/0001104659-26-018362.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-018362 |
| 2026-02-05 | 13:10 ET | [8-K](/filings/0001104659-26-010668.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-010668 |
| 2026-01-06 | 13:04 ET | [8-K](/filings/0001104659-26-001097.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-001097 |
| 2025-12-23 | 21:15 ET | [8-K/A](/filings/0001104659-25-124226.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-124226 |
| 2025-12-22 | 13:13 ET | [8-K](/filings/0001104659-25-123500.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-123500 |
| 2025-12-11 | 13:09 ET | [8-K](/filings/0001104659-25-120146.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-120146 |
| 2025-11-14 | 21:03 ET | [10-Q](/filings/0001829635-25-000004.md) | Quarterly report, period 2025-09-30 | 0001829635-25-000004 |
| 2025-10-28 | 21:39 ET | [SCHEDULE 13D/A](/filings/0001104659-25-103292.md) | Ownership report, active investor, amended | 0001104659-25-103292 |
| 2025-10-27 | 13:03 ET | [8-K](/filings/0001104659-25-102361.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-102361 |
| 2025-10-17 | 21:09 ET | [8-K/A](/filings/0001104659-25-100456.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-100456 |
| 2025-10-16 | 20:05 ET | [SCHEDULE 13D](/filings/0001104659-25-100081.md) | Ownership report, active investor | 0001104659-25-100081 |
| 2025-10-14 | 12:11 ET | [8-K](/filings/0001104659-25-099029.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-099029 |
| 2025-10-08 | 20:13 ET | [8-K/A](/filings/0001104659-25-097919.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-097919 |
| 2025-10-08 | 13:57 ET | [8-K](/filings/0001104659-25-097799.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-097799 |
| 2025-10-03 | 20:15 ET | [8-K](/filings/0001104659-25-096658.md) | 1.01 Entry into a material agreement | 0001104659-25-096658 |
| 2025-09-02 | 21:07 ET | [8-K](/filings/0001104659-25-086442.md) | 5.07 Shareholder vote results | 0001104659-25-086442 |
| 2025-08-14 | 20:15 ET | [10-Q](/filings/0001558370-25-011571.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011571 |
| 2025-07-15 | 20:14 ET | [DEF 14A](/filings/0001104659-25-068095.md) | Proxy statement, period 2025-08-29 | 0001104659-25-068095 |
| 2025-06-13 | 20:15 ET | [8-K](/filings/0001104659-25-059362.md) | 5.08 Item not in the standard list | 0001104659-25-059362 |
| 2025-05-14 | 20:15 ET | [10-Q](/filings/0001558370-25-007759.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007759 |
| 2025-05-07 | 20:45 ET | [8-K](/filings/0001104659-25-045598.md) | 3.01 Delisting notice | 0001104659-25-045598 |
| 2025-05-05 | 21:20 ET | [8-K](/filings/0001104659-25-044596.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-044596 |
| 2025-05-02 | 20:20 ET | [8-K](/filings/0001104659-25-044126.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-044126 |
| 2025-04-30 | 20:17 ET | [10-K/A](/filings/0001104659-25-042533.md) | Annual report, amended, period 2024-12-31 | 0001104659-25-042533 |
| 2025-04-21 | 20:40 ET | [8-K](/filings/0001104659-25-036866.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-036866 |
| 2025-04-15 | 20:38 ET | [10-K](/filings/0001558370-25-004843.md) | Annual report, period 2024-12-31 | 0001558370-25-004843 |

Page 1 of 3. [Older](/companies/rnaz/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.